Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription


1 Am Surg
2 Blood
2 Bone Marrow Transplant
1 Br J Dermatol
1 Eur J Haematol
3 Haematologica
1 Leuk Lymphoma
1 Leukemia
1 Mod Pathol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Surg

  1. SHAW T, Cockrell H, Panchal R, Abraham A, et al
    Burkitt Lymphoma Presenting as Perforated Appendicitis.
    Am Surg. 2021 Jul 4:31348211029854. doi: 10.1177/00031348211029854.
    PubMed         Abstract available


  2. HERRERA A, Cheng A, Mimitou EP, Seffens A, et al
    Multimodal single-cell analysis of cutaneous T cell lymphoma reveals distinct sub-clonal tissue-dependent signatures.
    Blood. 2021 Jul 7. pii: 476325. doi: 10.1182/blood.2020009346.
    PubMed         Abstract available

  3. ELUARD B, Nuan-Aliman S, Faumont N, Collares D, et al
    The alternative RelB NF-kappaB subunit is a novel critical player in diffuse large B-cell lymphoma.
    Blood. 2021 Jul 7. pii: 476326. doi: 10.1182/blood.2020010039.
    PubMed         Abstract available

    Bone Marrow Transplant

  4. CORTELAZZO S, Mian M, Evangelista A, Devizzi L, et al
    Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01391.

  5. PYTLIK R, Vackova B, Konirova E, Trnkova M, et al
    Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT.
    Bone Marrow Transplant. 2021;56:709-712.

    Br J Dermatol

  6. GAMBICHLER T, Boms S, Hessam S, Tischoff I, et al
    Primary cutaneous anaplastic large cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.
    Br J Dermatol. 2021 Jul 6. doi: 10.1111/bjd.20630.
    PubMed         Abstract available

    Eur J Haematol

  7. WIGHT J, Wai SH, Shen E, Lee ST, et al
    Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma.
    Eur J Haematol. 2021 Jul 8. doi: 10.1111/ejh.13684.
    PubMed         Abstract available


  8. STRATI P, De Vos S, Ruan J, Maddocks KJ, et al
    Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase 1b study.
    Haematologica. 2021 Jul 8. doi: 10.3324/haematol.2021.278654.
    PubMed         Abstract available

  9. RAM R, Grisariu S, Shargian-Alon L, Amit O, et al
    Toxicity and efficacy of chimeric antigen receptor T-cell in patients with diffuse large B cell lymphoma above the age of 70 years compare to younger patients - a matched control multi-center cohort study.
    Haematologica. 2021 Jul 8. doi: 10.3324/haematol.2021.278288.
    PubMed         Abstract available

  10. SVOBODA J, Bair SM, Landsburg DJ, Dwivedy Nasta S, et al
    Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
    Haematologica. 2021;106:1705-1713.
    PubMed         Abstract available

    Leuk Lymphoma

  11. ALLIOUX F, Gandhi D, Vilque JP, Nganoa C, et al
    End-of-treatment (18)F-FDG PET/CT in diffuse large B cell lymphoma patients: DeltaSUV outperforms Deauville score.
    Leuk Lymphoma. 2021 Jul 5:1-9. doi: 10.1080/10428194.2021.1948028.
    PubMed         Abstract available


  12. PRITCHETT JC, Yang ZZ, Kim HJ, Villasboas JC, et al
    High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL).
    Leukemia. 2021 Jul 6. pii: 10.1038/s41375-021-01321.
    PubMed         Abstract available

    Mod Pathol

  13. MEDEIROS LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, et al
    Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
    Mod Pathol. 2021 Jul 5. pii: 10.1038/s41379-021-00863.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.